Smith Julie

CIK 00015579284 companiesALAMEDA, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001557928

Recent Transactions

50 trades

Exercise/Conversion
EXELIXIS, INC.$EXEL
Common Stock
2026-02-18$19.39/sh+44,087→ 64,677 total
Exercise/Conversion
EXELIXIS, INC.$EXEL
Option (right to buy)
2026-02-18−20,030→ 0 total
Exercise/Conversion
EXELIXIS, INC.$EXEL
Option (right to buy)
2026-02-18−44,087→ 0 total
Sale
EXELIXIS, INC.$EXEL
Common Stock
2026-02-18$44.30/sh−20,030→ 20,590 total
Exercise/Conversion
EXELIXIS, INC.$EXEL
Common Stock
2026-02-18$21.69/sh+20,030→ 40,620 total
Sale
EXELIXIS, INC.$EXEL
Common Stock
2026-02-18$44.50/sh−44,087→ 20,590 total
Exercise/Conversion
EXELIXIS, INC.$EXEL
Common Stock
2026-02-17$18.19/sh+42,422→ 63,012 total
Exercise/Conversion
EXELIXIS, INC.$EXEL
Option (right to buy)
2026-02-17−42,422→ 0 total
Sale
EXELIXIS, INC.$EXEL
Common Stock
2026-02-17$43.33/sh−42,422→ 20,590 total
Award
Stoke Therapeutics, Inc.$STOK
Director Stock Option (Right to Buy)
2025-06-03+29,747→ 29,747 total
Award
EXELIXIS, INC.$EXEL
Common Stock
2025-05-29+9,812→ 20,590 total
Exercise/Conversion
EXELIXIS, INC.$EXEL
Common Stock
2025-02-28$19.77/sh+19,294→ 30,072 total
Sale
EXELIXIS, INC.$EXEL
Common Stock
2025-02-28$37.62/sh−19,294→ 10,778 total
Exercise/Conversion
EXELIXIS, INC.$EXEL
Option (right to buy)
2025-02-28−19,294→ 0 total
Exercise/Conversion
EXELIXIS, INC.$EXEL
Option (right to buy)
2025-02-27−23,347→ 19,294 total
Exercise/Conversion
EXELIXIS, INC.$EXEL
Option (right to buy)
2025-02-27−31,167→ 0 total
Sale
EXELIXIS, INC.$EXEL
Common Stock
2025-02-27$38.13/sh−54,514→ 10,778 total
Exercise/Conversion
EXELIXIS, INC.$EXEL
Common Stock
2025-02-27$20.50/sh+31,167→ 41,945 total
Exercise/Conversion
EXELIXIS, INC.$EXEL
Common Stock
2025-02-27$19.77/sh+23,347→ 65,292 total
Other
EXELIXIS, INC.$EXEL
Common Stock
2024-08-13−4,682→ 10,778 total
Award
Stoke Therapeutics, Inc.$STOK
Director Stock Option (Right to Buy)
2024-06-05+7,639→ 7,639 total
Award
EXELIXIS, INC.$EXEL
Common Stock
2024-05-31+10,015→ 15,460 total
Award
EXELIXIS, INC.$EXEL
Option (right to buy)
2024-05-31+20,030→ 20,030 total
Sale
EXELIXIS, INC.$EXEL
Common Stock
2024-05-21$21.12/sh−27,280→ 5,445 total
Award
Stoke Therapeutics, Inc.$STOK
Director Stock Option (Right to Buy)
2023-06-13+19,441→ 19,441 total
Award
EXELIXIS, INC.$EXEL
Option (right to buy)
2023-06-01+44,087→ 44,087 total
Award
Stoke Therapeutics, Inc.$STOK
Director Stock Option (Right to Buy)
2022-06-07+21,000→ 21,000 total
Award
EXELIXIS, INC.$EXEL
Option (right to buy)
2022-05-26+42,422→ 42,422 total
Award
Stoke Therapeutics, Inc.$STOK
Director Stock Option (Right to Buy)
2021-06-08+11,650→ 11,650 total
Award
EXELIXIS, INC.$EXEL
Common Stock
2021-05-27+16,424→ 32,725 total
Award
Stoke Therapeutics, Inc.$STOK
Director Stock Option (Right to Buy)
2020-06-03+29,555→ 29,555 total
Award
EXELIXIS, INC.$EXEL
Common Stock
2020-05-21+15,538→ 16,301 total
Disposition to Issuer
Audentes Therapeutics, Inc.
Stock Option (Right to Buy)
2020-01-15−9,000→ 0 total
Disposition to Issuer
Audentes Therapeutics, Inc.
Stock Option (Right to Buy)
2020-01-15−16,200→ 0 total
Disposition to Issuer
Audentes Therapeutics, Inc.
Stock Option (Right to Buy)
2020-01-15−10,000→ 0 total
Disposition to Issuer
Audentes Therapeutics, Inc.
Stock Option (Right to Buy)
2020-01-15−18,000→ 0 total
Award
EXELIXIS, INC.$EXEL
Option (right to buy)
2019-05-23+42,641→ 42,641 total
Award
Audentes Therapeutics, Inc.
Stock Option (right to buy)
2019-02-06+16,200→ 16,200 total
Award
Audentes Therapeutics, Inc.
Stock Option (right to buy)
2018-06-08+10,000→ 10,000 total
Award
EXELIXIS, INC.$EXEL
Option (right to buy)
2018-05-24+31,167→ 31,167 total
Award
Audentes Therapeutics, Inc.
Stock Option (right to buy)
2017-10-08+9,000→ 9,000 total
Award
EXELIXIS, INC.$EXEL
Option (right to buy)
2017-05-25+23,491→ 23,491 total
Award
EXELIXIS, INC.$EXEL
Option (right to buy)
2017-02-23+16,620→ 16,620 total
Award
Audentes Therapeutics, Inc.
Stock Option (right to buy)
2017-01-01+18,000→ 18,000 total
Disposition to Issuer
HORIZON PHARMACEUTICAL LLC
Stock Option(right to buy)
2016-10-25−152,050→ 0 total
Disposition to Issuer
HORIZON PHARMACEUTICAL LLC
Stock Option(right to buy)
2016-10-25−175,000→ 0 total
Disposition to Issuer
HORIZON PHARMACEUTICAL LLC
Common Stock
2016-10-25$9.00/sh−64,179→ 0 total
Disposition to Issuer
HORIZON PHARMACEUTICAL LLC
Stock Option(right to buy)
2016-10-25−240,595→ 0 total
Disposition from Tender
HORIZON PHARMACEUTICAL LLC
Common Stock
2016-10-24$9.00/sh−45,759→ 64,179 total
Award
EXELIXIS, INC.$EXEL
Common Stock
2016-09-22+763→ 763 total

Companies

Recent Filings

Address

C/O EXELIXIS, INC. 1851 HARBOR BAY PARKWAY

ALAMEDA, CA, 94502

View on SEC.gov